Trial Profile
Study assessing the single and multiple dose, safety and tolerability of an intravaginal ointment containing R131 in healthy female volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 15 Oct 2021
Price :
$35
*
At a glance
- Drugs Lopinavir/ritonavir (Primary)
- Indications Genitourinary disorders; HIV infections; Human papillomavirus infections
- Focus Adverse reactions; Pharmacokinetics
- 13 Oct 2021 Status changed from recruiting to completed.
- 30 May 2018 New trial record